Linagliptin
Home / API - Commercial / Linagliptin
CAS No.
668270-12-0
Therapeutic Category
- Anti-diabetic
Innovator Brand
TRAJENTA , JENTADUETO
GMP
Available
DMF
Available
Filed
-
Under Filing
Sample
Available
Indication
Tradjenta is a dipeptidyl peptidase-4 (dpp-4) inhibitor indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
Disclaimer: CTX Lifesciences respects patent laws and conventions of pharmaceuticals as applicable in different countries.
API/Substances covered by patent are not offered to the countries where the patent law is in force. However, the final responsibility lies with the customer.